fda warning letters glp-1 compounders october 2025 Congress Introduces SAFE Drugs Act of 2025, Expanding Oversight of Compounded Drugs and Telehealth Providers FDA warns against compounded GLP-1

If prescribed, patients receive instructions regarding medication administration, supplies, dosing guidance, and follow-up expectations

Cardiometabolic parameters during GLP-1 RA treatment GLP-1 RAs have also demonstrated important cardioprotective benefits that extend beyond their impact on BW loss

(National Academy Press) Brody T

429 Addressing this constraint, the development of a recombinant urate oxidase, rasburicase and pegloticase has shown superior efficacy in rapidly reducing uric acid plasma concentrations compared to allopurinol

The pivotal trials enrolled hundreds of subjects and used CT-measured visceral adipose tissue (VAT) as the primary endpoint, a harder measure than BMI or waist circumference

- Acts as a protective layer to resist UV damage and the destruction of collagen, keeping skin elasticity, preventing sun pigmentation, wrinkles, and early ageing